Synthesis and characterization of 2,3-diaminophenazine@CuhNFs and 2,3-diaminopyridine@CuhNFs: a new strategy to enhance anticancer activity

2026

Closed access Metadata (CSL-JSON)
DOI 10.1080/24701556.2026.2667229
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

In this study, synthesis and characterization of 2,3-diaminophenazine@CuhNFs and 2,3-diaminopyridine@CuhNFs were carried out. The morphologies of the synthesized CuhNFs were investigated using Fourier Transform Infrared spectrometry, scanning electron microscopy and energy dispersive X-ray, elemental mapping, and XRD spectroscopy. Organic compounds and synthesized nanoflowers were screened against human lung (A549) and breast (MCF-7) cancer cell lines. The results show that the tested compounds had cytotoxic activity in both cell lines. To support the in vitro part of the study, the MTT results were also examined by in silico approaches. The binding parameter values of compounds interacting via in silico with 1M17 and 3ERT crystal structures in molecular docking and important amino acids in the binding site were determined. The pharmacokinetic properties and toxicity of compounds were evaluated using ADMET analysis.